Speculation regarding a possible link between BlackRock and the DNA Protocol on the XRP Ledger is gaining traction in the crypto community.
Speculation on BlackRock and XDNA
According to market commentator Pumpius, BlackRock may have an indirect involvement in a blockchain initiative operating on the XRP Ledger. He associates one of the asset manager's assets, the iShares Genomics and Healthcare ETF, with the ticker XDNA, which is also used for a decentralized blockchain initiative. "It’s a perfect mirror of BlackRock’s ETF. A corporate ETF and its decentralized, on-chain twin," said Pumpius.
XRPL as an Institutional Blockchain
Pumpius noted that the XRP Ledger offers features suited to institutional adoption, including low transaction fees, rapid settlement, and established relationships with the banking sector. These features make it a rational selection for a high-value data tokenization initiative.
Funding and Asset Tokenization Plans
The presale portal is presented as evidence of a private funding phase aimed at institutional clients. Pumpius claims that the XDNA project could serve as a pilot for broader tokenization efforts. Should genomic data be successful, the same approaches could be used to tokenize bonds, equities, and properties.
While Pumpius raises interesting hypotheses, they remain unverified, and the lack of official statements from both BlackRock and Ripple only fuels ongoing discussions about institutional engagement in blockchain projects.
